The mature European CABG device market will contract modestly through 2026 as procedure volumes decline due to increasing use of PCI for the treatment of CAD; however, rising interest in OPCAB and minimally invasive approaches to CABG surgery will help to mitigate overall revenue declines to some extent.
This Medtech 360 Report provides high-level market metrics for the CABG device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
- Coronary Artery Bypass Graft Devices - Market Insights - Europe (Supplemental)
Author(s): Megha Maheshwari, MBA
Megha Maheshwari is a principal analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional cardiology, aortic repair, and coronary artery bypass graft device markets. In addition to a postgraduate diploma in Hospital Administration with a Certificate in International Medical Tourism and an Associate's degree in Nutrition and Child Care, Megha holds a Bachelor's degree in Physiotherapy from Hemwati Nandan Bahuguna Garhwal University and an MBA in Healthcare IT from NIMS University.